# Cognex Corp: overview

CGNX · Nasdaq · CIK 851205 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cgnx.md) · [Financials](/companies/cgnx/financials.md) · [Filings](/companies/cgnx/filings.md) · [Insiders](/companies/cgnx/insiders.md)

Latest reported revenue: [$291.3m](/filings/0000851205-26-000065.md) for Q2 FY2026, three months to 2026-07-05, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000851205-26-000065).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [235](/filings/0000851205-25-000064.md) | [230 d](/filings/0000851205-26-000012.md) | [216](/filings/0000851205-26-000040.md) | [249](/filings/0000851205-26-000065.md) | [277](/filings/0000851205-25-000064.md) | [252 d](/filings/0000851205-26-000012.md) | [268](/filings/0000851205-26-000040.md) | [291](/filings/0000851205-26-000065.md) |
| Gross margin | % | [67.9%](/filings/0000851205-25-000064.md) | [68.7% d](/filings/0000851205-26-000012.md) | [66.8%](/filings/0000851205-26-000040.md) | [67.4%](/filings/0000851205-26-000065.md) | [67.6%](/filings/0000851205-25-000064.md) | [65.7% d](/filings/0000851205-26-000012.md) | [71.1%](/filings/0000851205-26-000040.md) | [70.6%](/filings/0000851205-26-000065.md) |
| Operating margin | % | [13.4%](/filings/0000851205-25-000064.md) | [13.4% d](/filings/0000851205-26-000012.md) | [12.1%](/filings/0000851205-26-000040.md) | [17.4%](/filings/0000851205-26-000065.md) | [20.9%](/filings/0000851205-25-000064.md) | [14.0% d](/filings/0000851205-26-000012.md) | [22.3%](/filings/0000851205-26-000040.md) | [29.4%](/filings/0000851205-26-000065.md) |
| Net margin | % | [12.6%](/filings/0000851205-25-000064.md) | [12.3% d](/filings/0000851205-26-000012.md) | [10.9%](/filings/0000851205-26-000040.md) | [16.3%](/filings/0000851205-26-000065.md) | [6.4%](/filings/0000851205-25-000064.md) | [12.9% d](/filings/0000851205-26-000012.md) | [19.3%](/filings/0000851205-26-000040.md) | [25.0%](/filings/0000851205-26-000065.md) |
| Diluted EPS | $ per share | [0.17](/filings/0000851205-25-000064.md) | not reported | [0.14](/filings/0000851205-26-000040.md) | [0.24](/filings/0000851205-26-000065.md) | [0.10](/filings/0000851205-25-000064.md) | not reported | [0.31](/filings/0000851205-26-000040.md) | [0.43](/filings/0000851205-26-000065.md) |
| Free cash flow | $m | [51.9 d](/filings/0000851205-25-000064.md) | [49.3 d](/filings/0000851205-26-000012.md) | [38.0](/filings/0000851205-26-000040.md) | [40.4 d](/filings/0000851205-26-000065.md) | [86.0 d](/filings/0000851205-25-000064.md) | [72.3 d](/filings/0000851205-26-000012.md) | [42.3](/filings/0000851205-26-000040.md) | [67.6 d](/filings/0000851205-26-000065.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,037](/filings/0000851205-24-000027.md) | [1,006](/filings/0000851205-25-000012.md) | [838](/filings/0000851205-26-000012.md) | [915](/filings/0000851205-26-000012.md) | [994](/filings/0000851205-26-000012.md) |
| Gross margin | % | [73.3%](/filings/0000851205-24-000027.md) | [71.8%](/filings/0000851205-25-000012.md) | [71.8%](/filings/0000851205-26-000012.md) | [68.4%](/filings/0000851205-26-000012.md) | [66.9%](/filings/0000851205-26-000012.md) |
| Operating margin | % | [30.4%](/filings/0000851205-24-000027.md) | [24.5%](/filings/0000851205-25-000012.md) | [15.6%](/filings/0000851205-26-000012.md) | [12.6%](/filings/0000851205-26-000012.md) | [16.3%](/filings/0000851205-26-000012.md) |
| Net margin | % | [27.0%](/filings/0000851205-24-000027.md) | [21.4%](/filings/0000851205-25-000012.md) | [13.5%](/filings/0000851205-26-000012.md) | [11.6%](/filings/0000851205-26-000012.md) | [11.5%](/filings/0000851205-26-000012.md) |
| Diluted EPS | $ per share | [1.56](/filings/0000851205-24-000027.md) | [1.23](/filings/0000851205-25-000012.md) | [0.65](/filings/0000851205-26-000012.md) | [0.62](/filings/0000851205-26-000012.md) | [0.68](/filings/0000851205-26-000012.md) |
| Free cash flow | $m | [299](/filings/0000851205-24-000027.md) | [224](/filings/0000851205-25-000012.md) | [89.8](/filings/0000851205-26-000012.md) | [134](/filings/0000851205-26-000012.md) | [237](/filings/0000851205-26-000012.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cgnx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.16bn | 15,991,755 |  | Reduced −250,340 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $731.4m | 10,099,866 |  | Reduced −270,781 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $594.3m | 8,206,627 |  | Added +5,219,751 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $543.8m | 7,509,391 |  | Added +79,235 |
| [Pictet Asset Management Holding SA](/funds/1993888.md) | 2026-06-30 | $422.0m | 5,829,878 |  | Reduced −843,153 |
| [NORDEA INVESTMENT MANAGEMENT AB](/funds/1218210.md) | 2026-06-30 | $407.4m | 5,820,165 |  | Reduced −321,453 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $392.5m | 5,419,280 |  | Added +157,780 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $356.3m | 4,918,798 |  | Added +220,056 |
| [DISCIPLINED GROWTH INVESTORS INC /MN](/funds/1050442.md) | 2026-06-30 | $299.8m | 4,139,715 |  | Reduced −182,360 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $215.8m | 2,979,759 |  | Added +946,668 |

## Recent filings

[All 885 filings](/companies/cgnx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-22 | 07:01 ET | [8-K](/filings/0000851205-26-000071.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000851205-26-000071 |
| 2026-08-06 | 06:34 ET | [10-Q](/filings/0000851205-26-000065.md) | Quarterly report, period 2026-07-05 | 0000851205-26-000065 |
| 2026-08-05 | 16:32 ET | [8-K](/filings/0000851205-26-000061.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000851205-26-000061 |
| 2026-05-07 | 06:30 ET | [10-Q](/filings/0000851205-26-000040.md) | Quarterly report, period 2026-04-05 | 0000851205-26-000040 |
| 2026-05-06 | 16:32 ET | [8-K](/filings/0000851205-26-000037.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000851205-26-000037 |
| 2026-04-30 | 16:06 ET | [8-K](/filings/0000851205-26-000028.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000851205-26-000028 |
| 2026-03-13 | 08:01 ET | [DEF 14A](/filings/0001193125-26-105065.md) | Proxy statement, period 2026-04-29 | 0001193125-26-105065 |
| 2026-02-19 | 16:06 ET | [8-K/A](/filings/0000851205-26-000022.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000851205-26-000022 |
| 2026-02-17 | 08:01 ET | [8-K](/filings/0000851205-26-000018.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000851205-26-000018 |
| 2026-02-12 | 06:14 ET | [10-K](/filings/0000851205-26-000012.md) | Annual report, period 2025-12-31 | 0000851205-26-000012 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000851205-26-000012.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 851205
- Tickers: CGNX
- Exchange: Nasdaq
- SIC code: 3823 Industrial Instruments For Measurement, Display, and Control
- State of incorporation: MA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.